Medidata Blog

How Do Medical Device Companies View Risk-Based Monitoring and Does It Differ from Pharmaceuticals?

Reading Time: < 1 minute

 

When it comes to risk-based monitoring (RBM) in clinical research, how are studies conducted by medical device companies different from pharma studies? Medtronic International's Nurcan Coskun shares her thoughts, in the first of this two-part video series.*Guest blogger Nurcan Coskun is the district monitoring manager across Europe for clinical operations at Medtronic International. TWEET THIS:

[VIDEO] How Do Medical Device Companies View Risk-Based Monitoring & Does It Differ from Pharmaceuticals? @Medtronic http://t.co/g0UU8OrLXs

— Medidata (@Medidata) January 16, 2015

Medidata Solutions Image

Medidata Solutions